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Abstract 
The article presents the results of preventive efficacy of hepatoprotectors Hep-A-Stress and Hepasan-VS in laying 
hens with hepatosis. The research was conducted in modern poultry farm. Three groups of laying hens (control 
and two experimental) Lohmann Brown breed (n = 1500) aged 224 days were formed. The poultry was kept on the 
main ration according to the technological map for the use of this breed. Laying hens from the first experimental 
group were additionally given hepatoprotector Hep-A-Stress and the second – Hepasan-VS. Blood sampling for 
the study was performed three times: before the start of drug administration, after 10 and 30 days from the begin-
ning of hepatorotectors administration. The prophylactic effect of these drugs was determined by studying the 
preservation and productivity of poultry, interpretation of biochemical analysis of blood serum. The use of hepato-
protectors has allowed to increase the preservation and egg production of laying hens. The results of our studies 
showed insignificant changes of biochemical parameters in blood after 10 days administration of drugs, which 
indicates a slow effect of hepatoprotectors on the regenerative processes in the body of poultry. The prophylactic 
effect was established after 30 days use of hepatoprotectors. Our results showed that the use of these drugs had a 
positive effect on the protein-synthesizing function of the liver, as indicated by a decrease in serum total protein 
and an increase a albumin contents. There was also a positive effect on the intensity of protein metabolism, indi-
cated by decreased uric acid and an increased urea in the blood serum of experimental groups. The use of hepato-
protectors helped to reduce the activity of hepatospecific enzymes AST and ALT, which indicates the stabilization 
of cellular structures of hepatocytes. These drugs have increased the function of bile secretion, which is key of 
lipid metabolism, as evidenced by an increase in serum cholesterol. Thus, the use of these hepatoprotectors has a 
positive effect on metabolic processes in the body of laying hens, in particular, normalizes liver function and 
prevents the development of hepatosis. 
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The dynamic growth of the number of poultry of all spe-
cies is a feature of the current state of development of the 
poultry industry of Ukraine during the last decade (Melʹnyk 
& Ponomar, 2014; Melʹnyk, 2015). Therefore, there is a 
need for effective control over the health of poultry and the 
timeliness of treatment and prevention measures (Sokolov, 
2016; Dunets & Slivinska, 2017). 
Analyzing the research of recent years, it was found that 
liver disease is significantly more common among hens of 
egg productivity. In the structure of non-contagious diseases 
of poultry, according to a number of authors (Bessarov et 
al., 2009; Kal'berg & Sadovnykov, 2010; Sokolov & Ivanni-
kov, 2013; Melnyk, 2014), liver pathology (hepatosis or 
hepatodystrophy, hepatitis and liver cirrhosis) are diagnosed 
in 5.0–50.8 %. Therefore, timely diagnosis of the functional 
state of the liver of laying hens is actual, as pathological 
processes of this organ lead to irreversible processes, the 
development of disease and death (Dunets & Slivinslka, 
2018; Ostapyuk & Gutyj, 2019). 
The use of drugs with different spectrum of action is 
widely introduced into the scientific and practical compo-
nent of the poultry industry (Melnyk, 2017). Research on the 
impact of the development of liver pathologies on the 
productivity of poultry, which directly depend from the state 
of metabolic processes in the body, is gaining actual. There-
fore, the study of comprehensive and deep mechanisms of 
biochemical processes regulation in the body of poultry 
using drugs of different directions, primarily having hepato-
protective and anti-stress properties (Zhang et al., 2008; 
Ermashkevich & Kletikova, 2016).  
The solution to the problem of normalization of metabol-
ic processes in the poultry body and morphological and 
functional state of the liver with the use of hepatoprotective 
drugs is an important reserve for improving the efficiency of 
the poultry industry and production. It is necessary to im-
prove the methods of early diagnosis of liver dysfunction 
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(Kochish et al., 2004; Ezhkov, 2006; Sokolov & Ivannikov, 
2013). 
The purpose of our research – to compare the influence 
and determine the hepatoprotective effect of drugs Hep-A-
Stress and Hepasan-VS on the body of laying hens for 
prevention of hepatosis. 
 
2. Materials and methods 
 
The study was conducted in LLC (LIMITED LIABIL-
ITY COMPANY) Agrofirm “Zagai” of Kamiyanka-Buzkyi 
district of Lviv region and in laboratory of clinical and bio-
logical research of State Scientific-Research Control Insti-
tute of Veterinary Medicinal Products and Feed Additives. 
To achieve set goal, three groups of laying hens (control and 
two experimental) of the Lohmann Brown breed (n = 1500) 
aged 224 days were formed. At the poultry farm the hens 
were keep in a typical room equipped with 5-tier batteries 
with feeders, planting density of 10 heads per cage. 
Laying hens of control and experimental groups were 
kept on the main ration (MR) provided by the technological 
map for the use of this breed of poultry. The first 
experimental group hens were additionally given oral 
hepatoprotector Hep-A-Stress at a dose of 1 ml per 1 liter of 
drinking water for 10 days, and the second experimental 
group – hepatoprotector Hepasan-VS at a dose of 1 ml per 1 
liter of drinking water for 10 days, using a dispenser 
(Table 1). 
 
Table 1  
Scheme of production-experimental researches using hepatoprotectors 
 
Animal groups Scheme of researches The term of administration of hepatoprotectors 
The term of 
conducting 
researches 
Age of poultry 
(days) 
Control The main ration did not give 30 days 224 day 
Experimental 1 The main ration +  Hep-А-Stress (1 ml/l of water) 10 days 30 days 224 day 
Experimental 2 The main ration +  Hepasan-VS (1 ml/l of water) 10 days 30 days 224 day 
 
To establish the prophylactic efficacy, the preservation 
and egg productivity of the groups studied were evaluated. 
Daily egg laying was recorded by the number of eggs laid 
by each group of laying hens.  
The material for the study was blood, obtained in vivo 
from the subclavian vein, in compliance with the rules of 
aseptic and antiseptic. Serum biochemical analysis was 
performed in 30 hens from each group. Blood sampling in 
laying hens for research was performed three times: before 
the start given of drugs (224 days), after (234 days) and after 
30 days from the start after given hepatotectors (254 days).  
Serum total protein content and its fractions, aspartate 
(AST) and alanine (ALT) aminotransferase activity, choles-
terol level, urea concentration, uric acid were determined. 
The study was performed using a semi-automatic biochemi-
cal analyzer “HumaLyzer 3000” using Human Diagnostics 
Worldwide (Germany) reagents. The content of total protein 
was determined using an IRF-22 refractometer. The protein 
fractions in blood serum was determined by cellulose acetate 
electrophoresis using a Scan Power 300 and Scanion Lira 
400 microprobe electrophoresis devices, Hospitex Diagnos-
tics. 
Experimental study was performed in accordance to bio-
ethical standards in relation to animals that meet the re-
quirements of the Law of Ukraine № 3447-4 “On protection 
of animals from cruel treatment”, the provisions of Europe-
an Convention for the Protection of Vertebrate Animals, 
used for Experimental and Scientific Purposes (Strasbourg, 
1986). 
The results of biochemical studies are presented in ac-
cordance with the International System of Units recom-
mended for use in clinical laboratory practice. The analysis 
of research results was performed using a program package 
Statistica 6.0 software (Stat Soft, Tulsa, USA). Probability 
differences were assessed by Student's t-test. 
3. Results and discussion 
 
Results 
During the examination of poultry, metabolic disorders 
were diagnosed, which accounted for 90 % of pathologies of 
non-contagious etiology, and in 80 % of cases liver diseases 
were diagnosed. In addition, the analysis of the age dynam-
ics of hepatosis development in laying hens was performed 
(Dunets & Slivinska, 2018). Due to the results of biochemi-
cal analysis of blood serum, it was found that the most fa-
vorable for the development of hepatosis were laying hens 
300 and 530 days of age. However, the results of morpho-
logical examination of the liver indicate enlargement of 
organ and discomplexation of liver beams in 30 % of poul-
try aged 166 days (Yaremchuk et al., 2020). 
The analysis of the obtained data made it possible to de-
termine the nature of metabolic pathology, to identify the 
subclinical course of hepatosis in laying hens and to apply 
preventive measures, the ultimate goal of which is preserva-
tion of poultry and increase of its productivity (Dunets & 
Slivinska, 2018). 
Influence of hepatoprotectors Hep-A-Stress and 
Hepasan-VS on the preservation of poultry is shown in 
Table 2. At the beginning of the study, the number of 
poultry in each group was the same. In 10 days after the 
beginning of the study, it decreased in the control group, the 
first and second experimental groups on 0.9 %, 0.5 % and 
0.7 %, respectively. After drugs administration, the 
difference was 3 %, 1.7 % and 1.9 %, respectively, 
compared to the beginning of the study. The preservation of 
the control group of laying hens during our research was 
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Table 2 
Preservation of laying hens during the period of the research (n = 1500) 
 
Parameters Control Experimental 1 Experimental 2 
The number of poultry before the use of hepatoprotectors 1500 1500 1500 
The number of poultry after 10 days 1487 1492 1490 
The number of poultry after 30 days 1456 1475 1472 
Mortality for the period of research 44 25 28 
Preservation of poultry, % 97.1 98.3 98.1 
 
During the experimental period, the number of eggs in 
the control and experimental groups was recorded daily, the 
results are presented in table 3. It was established that during 
10 days of the experiment 14070 eggs were received from 
1500 laying hens of the control group with egg production 
of 93.8 %, in the first experimental group – 14265 eggs 
(95.1 %), in the second – 14,175 eggs (94.5 %). During 
30 days of the experimental period from the control and 
experimental groups gave 40635, 42435 and 42255 eggs, 
respectively, and egg production was 90.3 %, 94.3 % and 
93.9 %. At the end of the experimental period, the inter-
group difference in egg production of the first and second 




Egg productivity of laying hens in groups (n = 1500) 
 
Animal groups 
The beginning of the experiment after 10 days after 30 days 
number of eggs per day number of eggs, pcs. number of eggs, pcs. 
for laying hens/eggs, 
pcs. 
Control 1431 14070 40635 27.09 
Experimental 1 1429 14265 42435 28.29 
Experimental 2 1425 14175 42255 28.17 
 
It is known that the blood parameters of poultry, in par-
ticular of laying hens, depends on many factors (physiologi-
cal condition, age of the poultry, ration, productivity period, 
etc.). We studied the main parameters of blood, which re-
flect the state of metabolic processes in the poultry body and 
are diagnostic criteria for liver pathology. 
According to the results of biochemical study of the 
blood serum of laying hens after administration of hepato-
protectors (after 10 days) in a control, first and second ex-
perimental groups, it was established that the content of total 
protein was 70.7 ± 0.64 g/L; 66.7 ± 0.48 g/L and  
67.1 ± 0.68 g/L, respectively. This parameter was 6 % lower 
in the first experimental group and 5.4 % in the second 
comparing to the control group. The content of albumins in 
the first experimental group was the highest, 3.8 % higher 
compared to the control group. In the second experimental 
group there were no probable changes in this indicator  
(0.3 %, P > 0.5). After 10 days of hepatoprotectors adminis-
ration, the total cholesterol content was 17.4 % lower in the 
first experimental group and 8 % lower in the second com-
paring to the control group. The activity of the hepatospecif-
ic enzyme AST in the experimental groups had slight fluctu-
ations and probably did not change (Table 4). In contrast, 
ALT activity was 25.3 % lower in the experimental groups 
comparing to the control group. The concentration of uric 
acid in the serum was 4.2 % lower in the first experimental 
group comparing to the control group and 3.5 % lower com-
pared to the second experimental group. The urea content in 
the second experimental group did not differ from the aver-
age value of this parameter in the second experimental 
group. In the first experimental group, it was 15.8 % higher. 
 
Table 4 
Biochemical analysis of blood serum of laying hens (М ± m, n = 30) 
 













Control in 10 days Lim  65.5–76.3     32–41.8  165.1–202.0    7.9–10.1  1.9–3.4  338.7–540.5  1.7–2.2 M ± m 70.7 ± 0.64 37.1 ± 0.56 182.3 ± 1.85   9.0 ± 0.13 2.7 ± 0.07 424.6 ± 14.02 1.9 ± 0.03 
Experi-
mental 1 in 10 days 
Lim  61.2–70.3  34.8–41.8  168.6–189.3  10.2–13.5  1.9–2.7 367–513.6  1,7–2,6 
M ± m 66.7 ± 048           ººº 
38.5 ± 0.37  
        º 
177.5 ± 1.3 
          º 
11.9 ± 0.18 
       ººº 
2.3 ± 0.05  
     ººº 
407.6 ± 7.74 
          ºº 
2.2 ± 0.06  
     ººº 
Experi-
mental 2 in 10 days 
Lim 61.2–72.0  33.5–40.2  158.4–198.5  10.6–13.9  1.9–2.9  333.7–549  1.3–2.3 
M ± m 67.1 ± 0.68         ºº 
37.0 ± 0.41 178.6 ± 2.52 11.9 ± 0.19      
       ººº 
2.5 ± 0.05  
       º 
421.7 ± 10.31 1.9 ± 0.05 
Note: º – P < 0.05; ºº – P < 0.01; ººº – P < 0.001 – compared to the parameters of control group 
 
Thus, the use of drugs Hep-A-Stress and Hepasan-VS on 
the 10th day of the experiment did not significantly affect 
protein homeostasis and functional state of the liver. 
To control the prophylactic efficacy of hepatoprotectors, 
a repeated study of poultry was conducted with analysis of 
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biochemical parameters of the blood serum of laying hens 
after 30 days from the start of drugs use (254 days).  
Blood proteins perform numerous functions: maintaining 
the level of oncotic pressure, blood pH, blood cation levels, 
play an important role in the formation of immunity  
(Sharonina et al., 2016). Albumins are formed in hepato-
cytes, globulins – in cells of the reticuloendothelial system 
of the bone marrow and reticuloendothelial (Kupffer or 
stellate) cells of the liver. Therefore, the increase or decrease 
in serum protein largely depends on the condition of the 
liver (Thomson et al., 2003; Trott et al., 2014). 
At the beginning of the study, statistically significant dif-
ferences between the parameters of the content of total pro-
tein in the serum of the control and experimental groups 
were not found (Table 5). This parameter ranged from 68.2 
to 69.4 g/L. Thirty days after drug administration, the con-
tent of serum total protein of laying hens of the control 
group increased on 2.3 % (P > 0.1) and amounted to  
71.0 ± 0.46 g/L, indicating a violation of protein synthesis 
and development of dystrophic processes in the liver. In the 
first and second experimental groups, this indicator  
(P < 0.001) decreased on 21.4 % and 18.9 % compared with 
animals before drugs administration and on 26.3 % and 
23.3 % (P < 0.001) compared to the control group after 
administration. 
The decrease of the content of total protein in the blood 
serum of laying hens of the experimental groups was due to 
an increase in the content of albumins and a decrease in 
globulin fractions. In the first and second experimental 
groups, the albumin content increased on 5.7 % (P < 0.001) 
and on 3 % (P < 0.05) compared to parameters before using 
drugs. This parameter was also higher in laying hens of the 
experimental groups on 5.4 % (P < 0.001) and on 2.2 % 
(P < 0.05) compared to poultry of the control group. 
 
Table 5 
The content of serum total protein (g/L) and it fractions (%) in laying hens (М ± m, n = 30) 
 









α1 α2 β γ 
Control 
The beginning of 
the experiment M ± m 69.4 ± 0,84 37.6 ± 0.41 5.7 ± 0.46 12.3 ± 0.33 14.8 ± 0.64 29.7 ± 0.74 
in 30 days M ± m 71.0 ± 0.46 37.1 ± 0.25 8.8 ± 0.14 12.2 ± 0.11 19.1 ± 0.21 22.8 ± 0.25 
Experi-
mental 1 
The beginning of 
the experiment M ± m 
68.2 ± 0.84  
*** 37.0 ± 0.24 8.0 ± 0.47 11.4 ± 0.46 20.7 ± 0.56 22.9 ± 0.85 
in 30 days M ± m 56.2 ± 0.58  ººº 
39.1 ± 0.24 
ººº *** 
6.4 ± 0.28 11.5 ± 0.19 21.6 ± 0.38 21.5 ± 0.37 
Experi-
mental 2 
The beginning of 
the experiment M ± m 
68.5 ± 0.76  
*** 
36.8 ± 0.37 9.9 ± 0.47 13.6 ± 0.72 18.7 ± 0.63 21.0 ± 0.37 
in 30 days M ± m 57.6 ± 0.66  ºº 
37.9 ± 0.20 
º * 
8.2 ± 0.15 11.5 ± 0.18 20.7 ± 0.15 21.7 ± 0.30 
Note: * – P < 0.05; **– P < 0.01; ***– P < 0.001– compared to the parameters of group before giving hepatoprotectors; º– P < 0.05;  
ºº – P<0.01; ººº – P < 0.001– compared to the parameters of control group 
 
It is important to note that 30 days after the use of hepa-
toprotectors, an increase in total protein and albumin content 
in the experimental groups indicates a positive effect of 
drugs on the formation of liver protein synthesis. 
Evaluation of liver function was performed by studying 
hepatospecific serum enzymes – alanine and aspartate ami-
notransferase activity. It was established that the activity of 
alanine aminotransferase in the blood of laying hens of the 
control group at the beginning of the experiment was  
9.5 ± 0.25 U/L (Fig. 1). During the experimental period, a 
slight increase (on 13.7 %, P < 0.01) of the activity of this 
enzyme in the blood of this group to 10.8 ± 0.23 U/L was 
observed. It should be noted positive changes in ALT in the 
serum of experimental groups. This is evidenced by a de-
crease in this parameter in the first experimental group after 
administration of drugs on 43.7 % and 24.1 % (P < 0.001) 
compared to the control group. A similar tendency was 
found in the second experimental group, where the activity 
of this parameter decreased on 23.4 % (P < 0.001) after 
administration of drugs and on 14.9 % (P < 0.001) compared 
to the control group. 
 
 
Fig. 1. Activity of ALT in the blood serum before and 30 days after using hepatoprotectors (U/L, n = 30) 
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The activity of AST had a similar tendency (Fig. 2). It 
was found that this parameter in the serum of the control 
group after administration of drugs had insignificant chang-
es and increased on 3.3 % (P < 0.01). Thirty days after drugs 
administration, AST activity decreased in the first and sec-
ond experimental groups on 10.7 % (P < 0.001) and on  
7.7 % (P < 0.01), respectively. Also, this parameter in the 
experimental groups was lower compared to the control 
group after administration of drugs on 11.9 % and 10.1 % 
(P < 0.001) respectively. 
 
 
Fig. 2. Activity of AST in the blood serum before and 30 days after using hepatoprotectors (U/L, n = 30) 
 
The use of hepatoprotectors reduced the activity of ALT 
and AST in the serum of laying hens of experimental 
groups, which indicates the stabilization of cellular struc-
tures of hepatocytes, in particular mitochondrial and cyto-
solic. 
One of the important parameters of lipid metabolism is 
cholesterol. In first blood sampling (the beginning of the 
experiment) its level in the control group was  
2.4 ± 0.07 mmol/L, in the first experimental group –  
1.9 ± 0.04 mmol/L and in the second – 2.1 ± 0.04 mmol/L  
(Fig. 3). In 30 days after administration of hepatoprotectors 
the cholesterol content of the first experimental group con-
siderably increased, on 42.1 % (P < 0.001) compared to the 
parameter before giving the drugs of the same group and on 
35 % (P < 0.001) compared to the control group after ad-
ministration of drugs. A similar tendency was observed in 
the second experimental group. The level of total cholesterol 
was 23.8 % higher and 30 % higher (P < 0.001), respective-
ly. The difference between the average values of this param-
eter of the experimental groups after drug administration 
was 3.8 % (P > 0.1). The increase of cholesterol content in 
the experimental groups is probably due to increased bile 
function, which is key in lipid metabolism. 
 
 
Fig. 3. The cholesterol level in the blood serum before and 30 days after using hepatoprotectors (mmol/l, n = 30) 
 
The content of serum uric acid of the control group be-
fore using hepatoprotectors was 412.5 μmol/L, 30 days later 
– 427.0 ± 7.98 μmol/L (+3.5 %, P > 0.1). The opposite dy-
namics was observed in the experimental groups (Fig. 4). In 
30 days after the use of drugs in the first and second exper-
imental groups, the content of uric acid decreased on 14.6 % 
(P < 0.01) and 18.8 % (P < 0.05) compared to the beginning 
of the experiment and was lower on 13.7 % (P < 0.01) and 
8.2 % (P > 0.1) compared to the control group in the same 
selection. 
It should be noted that the content of serum urea in the 
control group before and after 30 days use of hepatoprotec-
tors did not differ (P > 0.5) (Fig. 5). After administration of 
drugs, this parameter increased on 19 % (P < 0.001) and on 
10.5 % (P < 0.05) in the first and second experimental 
groups. An increase in urea content was also found in the 
experimental groups after the use of hepatoprotectors com-
pared to the control group at the same age (in first experi-
mental – on 25 % (P < 0.001) and second experimental – on 
5 % (P > 0.1)). These changes indicate an increase in the 
intensity of protein metabolism. 
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Fig. 4. The content of serum uric acid before and 30 days after using hepatoprotectors (μmol/l, n = 30) 
 
 
Fig. 5. The content of serum urea before and 30 days after using hepatoprotectors (mmol/l, n = 30) 
 
Discussion 
Analyzing the data of scientific publications, we found 
that since the 1950s, extensive research has been conducted 
on the etiological factors and prevention of avian hepatosis, 
especially in laying hens. However, these issues are still not 
fully understood (Shini & Wayne, 2009; Kuz'minova et al., 
2014). 
Prevention of non-contagious pathologies of poultry as-
sociated with metabolic disorders, in particular hepatosis of 
laying hens is a priority for veterinary medicine. This is 
possible due to the use of vitamin, hepatoprotective, anti-
stress and other drugs (Burkov & Scherbakov, 2012;  
Katyukha et al., 2017). 
Currently, hepatoprotectors are widely used as a preven-
tive measure that helps maintain the structural integrity and 
functional activity of the liver in the stressful conditions of 
industrial production of eggs and poultry meat (Surai, 2019). 
These drugs provide intensive growth, development and 
high productivity of poultry. Characterizing the mechanism 
of action of hepatoprotectors, it should be noted that these 
drugs affect the pathogenesis, not the cause of the disease. 
The pathogenesis of liver pathologies is based on damage of 
cellular elements (mainly hepatocytes), which leads to dys-
function, dystrophic changes, inflammation, cytolysis, ne-
crosis or fibrosis (Avdosieva et al., 2014). 
Two types of hepatoprotectors were used in our research. 
The composition of the preparation Hep-A-Stress includes 
carnitine hydrochloride, D, L methionine, sorbitol, choline 
chloride, magnesium sulfate heptahydrate. The content of 
active substances of the preparation Hepasan-VS – L-
carnitine hydrochloride, sorbitol, choline chloride, magnesi-
um sulfate heptahydrate, betaine hydrochloride, L-arginine. 
The main active ingredient of used hepatoprotectors is a 
carnitine (Yakovleva et al., 2011). It is known that it is par-
tially synthesized in the body and performs various func-
tions (antioxidant, anti-inflammatory, energy conversion, 
lipid lowering, mitochondrial regulator, activation of vita-
mins, membrane stabilization, protection against apoptosis, 
glucose homeostasis). However, its main hepatoprotective 
effect is manifested at the level of vitamins and transcription 
factors (Surai, 2019). Carnitine is a component of carnitine 
transferase, which transports the products of hydrolysis of 
fats – fatty acids in the mitochondria of hepatocytes, where 
they are subjected to β-oxidation with the formation of ace-
tic acid and its subsequent condensation with oxaloacetic 
acid, citric acid is formed, which enters the reaction of the 
tricarbonate cycle. 
Choline in hepatocytes reacts with fat, choline phospha-
tides are formed, which provide a constant outflow of fatty 
substances from the liver into the bloodstream and prevent 
the development of fatty dystrophy of hepatocytes. Thus, 
choline has a lipotropic effect. 
The choline molecule has labile methyl groups required 
for many tissue synthesis reactions. However, they are only 
used if there is sufficient number of methionine. In addition, 
methionine affects the disposal of toxins, slows the deposi-
tion of neutral fat in the liver, has a lipotropic effect (remov-
al of excess fat from the liver) (Lemesheva et al., 2002). 
Thus, the components of the drugs Hep-A-Stress and 
Hepasan-VS L-carnitine, choline chloride and methionine 
have a positive effect on the structure of hepatocytes and the 
functional state of the liver as a whole. 
 
 




The use of hepatoprotectors Hep-A-Stress and Hepasan-
VS stimulate metabolism and has a positive effect on blood 
parameters in laying hens. It should be noted that the effect 
of  drugs  on  the  body  of  the  bird  is  slow,  as  evidenced  by  
insignificant changes in serum biochemical analysis after 10 
days  of  the  experiment.  The  prophylactic  effect  of  hepato-
protectors was established after 30 days of their use. Name-
ly,  a  positive  effect  on  protein  synthesis,  stabilization  of  
cellular  structures  of  hepatocytes and enhancement  of  bile  
secretion.  The  use  of  hepatoprotectors  also  had  a  positive  
effect  on  the  poultry  preservation and  egg  production  of  
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